Guardant Health (GH)
(Real Time Quote from BATS)
$24.21 USD
+0.48 (2.02%)
Updated Sep 9, 2024 10:16 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
GH 24.21 +0.48(2.02%)
Will GH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GH
Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average
Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
GH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings
Merus N.V. (MRUS) Reports Q2 Loss, Lags Revenue Estimates
Other News for GH
What's Driving Sotera Health Co's Surprising 32% Stock Rally?
Guardant Health management to meet with Craig-Hallum
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration
Boeing's Starliner to return without astronauts: Morning Buzz